Factory 99% Febuxostat Powder CAS 144060-53-7 Anti-Gout Febuxostat

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A254
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Febuxostat
• CAS: 144060-53-7
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 100g
• Function: Anti-Gout
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Febuxostat
Appearance	White Powder
CAS NO.	144060-53-7
Molecular Formula	C16H16N2O3S
Storage	Keep in a cool, dry, dark location

 

Febuxostat, also known by its trade name Uloric, is a potent and selective inhibitor of xanthine oxidase, an enzyme crucial for the production of uric acid in the body. With the molecular formula C16H16N2O3S, it belongs to a class of medications known as xanthine oxidase inhibitors. This medication is primarily used in the management of hyperuricemia, a medical condition characterized by abnormally high levels of uric acid in the blood, and the prevention of gout flares, which are painful inflammations of the joints caused by the deposition of uric acid crystals.

 

 

1. Hyperuricemia Management: Febuxostat is prescribed to individuals with hyperuricemia to help maintain normal uric acid levels, thereby reducing the risk of gout attacks and other complications associated with elevated uric acid levels.
2. Gout Prevention: By inhibiting the production of uric acid, febuxostat helps prevent the formation of uric acid crystals in the joints, which can trigger gout flares.
3. Adjunct Therapy: In addition to dietary modifications and other therapeutic measures, febuxostat can be used as an adjunct therapy in the comprehensive management of gout.

1. Xanthine Oxidase Inhibition: Febuxostat selectively binds to and inhibits the activity of xanthine oxidase, an enzyme responsible for converting hypoxanthine and xanthine to uric acid.
2. Uric Acid Reduction: By inhibiting xanthine oxidase, febuxostat reduces the amount of uric acid produced by the body, thereby lowering blood uric acid levels and preventing the formation of uric acid crystals.
3. Anti-inflammatory and Analgesic Effects: Although its primary mechanism of action is uric acid reduction, febuxostat may also exhibit anti-inflammatory and analgesic properties, contributing to its efficacy in reducing pain and inflammation associated with gout attacks.